You are here

Article info

Article menu

Download PDFPDF

XML
Global health
Original research
Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis

Authors

  • Hemalkumar B Mehta Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USACenter for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Stephan Ehrhardt Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Thomas J Moore Institute for Safe Medication Practices, Alexandria, Virginia, USA PubMed articlesGoogle scholar articles
  • Jodi B Segal Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USACenter for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USADepartment of Health Policy and Management, Johns Hopkins Bloomberg School of Public health, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • G Caleb Alexander Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USACenter for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr G Caleb Alexander; galexan9{at}jhmi.edu
View Full Text

Citation

Mehta HB, Ehrhardt S, Moore TJ, et al
Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis
BMJ Open 2020;10:e039978. doi: 10.1136/bmjopen-2020-039978

Publication history

  • Received May 1, 2020
  • Revised May 11, 2020
  • Accepted May 12, 2020
  • First published June 9, 2020.
Online issue publication 
June 09, 2020
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.